Showing 1 - 5 results of 5 for search 'Masao Sasamata', query time: 0.02s Refine Results
  1. 1
    The Forefront for Novel Therapeutic Agents Based on the Pathophysiology of Lower Urinary Tract Dysfunction: Ameliorative Effect of Solifenacin Succinate (Vesicare ®), a Bladder-Selective Antimuscarinic Agent, on Overactive Bladder Symptoms, Especially Urgency Episodes

    The Forefront for Novel Therapeutic Agents Based on the Pathophysiology of Lower Urinary Tract Dysfunction: Ameliorative Effect of Solifenacin Succinate (Vesicare ®), a Bladder-Sel... by Akiyoshi Ohtake, Shuichi Sato, Masao Sasamata, Keiji Miyata

    Published 2010-01-01
    Get full text
    Article
  2. 2
    New Topics in Vasopressin Receptors and Approach to Novel Drugs: Research and Development of Conivaptan Hydrochloride (YM087), a Drug for the Treatment of Hyponatremia

    New Topics in Vasopressin Receptors and Approach to Novel Drugs: Research and Development of Conivaptan Hydrochloride (YM087), a Drug for the Treatment of Hyponatremia by Yukinori Arai, Akira Fujimori, Masao Sasamata, Keiji Miyata

    Published 2009-01-01
    Get full text
    Article
  3. 3
    Evaluation of the Pharmacological Profile of Ramosetron, a Novel Therapeutic Agent for Irritable Bowel Syndrome

    Evaluation of the Pharmacological Profile of Ramosetron, a Novel Therapeutic Agent for Irritable Bowel Syndrome by Takuya Hirata, Yoshihiro Keto, Toshiyuki Funatsu, Shinobu Akuzawa, Masao Sasamata

    Published 2007-01-01
    Get full text
    Article
  4. 4
    Inhibitory Effects of Ramosetron, a Potent and Selective 5-HT3–Receptor Antagonist, on Conditioned Fear Stress–Induced Abnormal Defecation and Normal Defecation in Rats: Comparative Studies With Antidiarrheal and Spasmolytic Agents

    Inhibitory Effects of Ramosetron, a Potent and Selective 5-HT3–Receptor Antagonist, on Conditioned Fear Stress–Induced Abnormal Defecation and Normal Defecation in Rats: Comparativ... by Takuya Hirata, Toshiyuki Funatsu, Yoshihiro Keto, Shinobu Akuzawa, Masao Sasamata, Keiji Miyata

    Published 2008-01-01
    Get full text
    Article
  5. 5
    Antidiabetic Effects of SGLT2-Selective Inhibitor Ipragliflozin in Streptozotocin–Nicotinamide-Induced Mildly Diabetic Mice

    Antidiabetic Effects of SGLT2-Selective Inhibitor Ipragliflozin in Streptozotocin–Nicotinamide-Induced Mildly Diabetic Mice by Atsuo Tahara, Eiji Kurosaki, Masanori Yokono, Daisuke Yamajuku, Rumi Kihara, Yuka Hayashizaki, Toshiyuki Takasu, Masakazu Imamura, Li Qun, Hiroshi Tomiyama, Yoshinori Kobayashi, Atsushi Noda, Masao Sasamata, Masayuki Shibasaki

    Published 2012-01-01
    Get full text
    Article

Search Tools: